RENASANT BIO
Live / Allowed — Approved for publication (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99490541
- Mark type
- Stylized text
- Filed
- 11 Nov 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of polycystic kidney disease, namely, autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical preparations for modulating polycystin ion channels for the treatment of autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical preparations for the treatment of kidney diseases and disorders; Pharmaceutical preparations for ion channel modulators for the treatment of kidney diseases and disorders; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, kidney diseases and disorders; Pharmaceutical preparations for the treatment of genetic kidney diseases
- Class 042 — Scientific and technological services: Pharmaceutical research in the field of kidney diseases and disorders; Pharmaceutical research in the field of drug discovery for kidney diseases and disorders; Pharmaceutical research in the field of autosomal dominant polycystic kidney disease (ADPKD); Pharmaceutical research in the field of ion channel pharmacology and electrophysiology related to kidney diseases and disorders; Research and development in the field of kidney diseases and disorders; Medical and scientific research information in the field of kidney diseases and disorders; Scientific and technological services, namely, design and development of biological assays for scientific research purposes in the field of kidney disease drug discovery and development
Owner
- Renasant Bio, Inc., Berkeley, CA, US
Prosecution history
- 01 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Apr 2026 — EXAMINER'S AMENDMENT ENTERED
- 01 Apr 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Apr 2026 — EXAMINERS AMENDMENT E-MAILED
- 01 Apr 2026 — EXAMINERS AMENDMENT -WRITTEN
- 31 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN
- 20 Mar 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 11 Nov 2025 — NEW APPLICATION ENTERED